Extendicare Inc. (TSE:EXE – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as C$27.44 and last traded at C$26.56, with a volume of 57784 shares. The stock had previously closed at C$26.58.
Analyst Ratings Changes
EXE has been the topic of several research reports. TD Securities raised their price target on shares of Extendicare from C$15.00 to C$19.00 in a report on Thursday, November 13th. Canaccord Genuity Group lifted their target price on shares of Extendicare from C$20.00 to C$22.50 in a report on Thursday, December 4th. National Bank Financial increased their price target on Extendicare from C$24.50 to C$29.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Canadian Imperial Bank of Commerce boosted their price objective on Extendicare from C$18.00 to C$22.00 in a research note on Thursday, November 13th. Finally, BMO Capital Markets upgraded Extendicare from a “hold” rating to an “outperform” rating and increased their target price for the company from C$21.00 to C$24.00 in a research note on Thursday, December 4th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of C$24.50.
View Our Latest Analysis on Extendicare
Extendicare Stock Performance
Extendicare (TSE:EXE – Get Free Report) last posted its quarterly earnings data on Thursday, February 26th. The company reported C$0.29 earnings per share for the quarter. The company had revenue of C$462.03 million during the quarter. Extendicare had a net margin of 4.48% and a return on equity of 64.13%. Analysts forecast that Extendicare Inc. will post 0.6134729 earnings per share for the current year.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- ATCX is Sitting on One of Brazil’s Largest Critical Minerals Portfolios!
- A Rockefeller Moment Is Unfolding in Rare Earths
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- 1,500 Banks Just Handed the Fed Your Bank Account
- America’s 1776 happening again
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
